|
"jy shih"的相關文件
顯示項目 1-13 / 13 (共1頁)
1
每頁顯示[10|25|50]項目
| 中山醫學大學 |
2018-04-14 |
Exercise intervention attenuates hyperhomocysteinemia-induced aortic endothelial oxidative injury by regulating SIRT1 through mitigating NADPH oxidase/LOX-1 signaling
|
SH, Chan; CH, Hung; JY, Shih; PM, Chu; YH, Cheng; HC, Lin; PL, Hsieh; KL, Tsai |
| 大葉大學 |
2016-03 |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients.
|
SG, Wu;YN, Liu;Tsai, Meng-Feng;YL, Chang;CJ, Yu;PC, Yang;JC, Yang;Wen, Yueh-Feng;JY, Shih |
| 大葉大學 |
2016-02 |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients.
|
SG, Wu;YN, Liu;Tsai, Meng-Feng;YL, Chang;CJ, Yu;PC, Yang;JC, Yang;Wen, Yueh-Feng;JY, Shih |
| 大葉大學 |
2015-09 |
EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway.
|
Tsai, Meng-Feng;TH, Chang;SG, Wu;HY, Yang;YC, Hsu;PC, Yang;JY, Shih |
| 大葉大學 |
2014-08-9 |
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ROS1 fusion in comparison with other driver mutations in East Asian populations.
|
YF, Chen;MS, Hsieh;SG, Wu;YL, Chang;JY, Shih;YN, Liu;Tsai, Meng-Feng;TH, Tsai;CJ, Yu;JC, Yang;PC, Yang |
| 大葉大學 |
2014-08-09 |
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ROS1 fusion in comparison with other driver mutations in East Asian populations.
|
YF, Chen;MS, Hsieh;SG, Wu;YL, Chang;JY, Shih;YN, Liu;Tsai, Meng-Feng;TH, Tsai;CJ, Yu;JC, Yang;PC, Yang |
| 大葉大學 |
2013-06-1 |
Survival of lung adenocarcinoma patients with malignant pleural effusion
|
SG, Wu;CJ, Yu;Tsai, Meng-Feng;WY, Liao;CH, Yang;IS, Jan;PC, Yang;JY, Shih |
| 大葉大學 |
2013-06-01 |
Survival of lung adenocarcinoma patients with malignant pleural effusion
|
SG, Wu;CJ, Yu;Tsai, Meng-Feng;WY, Liao;CH, Yang;IS, Jan;PC, Yang;JY, Shih |
| 大葉大學 |
2012-01-15 |
EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with wild-type EGFR.
|
SG, Wu;YW, Kuo;YL, Chang;JY, Shih;YH, Chen;Tsai, Meng-Feng;CJ, Yu;CH, Yang;PC, Yang |
| 大葉大學 |
2010-03-1 |
Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma.
|
CT, Huang;RF, Yen;MF, Cheng;YC, Hsu;PF, Wei;YJ, Tsai;Tsai, Meng-Feng;JY, Shih;CH, Yang;PC, Yang |
| 大葉大學 |
2010-03-01 |
Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma.
|
CT, Huang;RF, Yen;MF, Cheng;YC, Hsu;PF, Wei;YJ, Tsai;Tsai, Meng-Feng;JY, Shih;CH, Yang;PC, Yang |
| 大葉大學 |
2009-04-1 |
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naïve non-small-cell lung cancer
|
CH, Gow;YL, Chang;YC, Hsu;Tsai, Meng-Feng;CT, Wu;CJ, Yu;CH, Yang;YC, Lee;PC, Yang;JY, Shih |
| 大葉大學 |
2009-04-01 |
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naïve non-small-cell lung cancer
|
CH, Gow;YL, Chang;YC, Hsu;Tsai, Meng-Feng;CT, Wu;CJ, Yu;CH, Yang;YC, Lee;PC, Yang;JY, Shih |
顯示項目 1-13 / 13 (共1頁)
1
每頁顯示[10|25|50]項目
|
